VICORE Trademark

Trademark Overview


On Thursday, January 23, 2020, a trademark application was filed for VICORE with the United States Patent and Trademark Office. The USPTO has given the VICORE trademark a serial number of 79283880. The federal status of this trademark filing is REGISTERED as of Tuesday, July 6, 2021. This trademark is owned by Vicore Pharma AB. The VICORE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals and medical preparations for human use, namely, prescription drugs, namely, pills, tablets, capsules, caplets, and liquid drops sachets for the treatment fibrotic lung disease

Medical and pharmacological research services; medical and pharmacological research services within the fields of pulmonary diseases, cardiovascular diseases, autoimmune and inflammatory diseases, fibrotic diseases and kidney diseases; medical and pharmacological research services within the fields of pulmonary fibrosis, namely, ipf, pulmonary sarcoidosis and diffuse systemic sclerosis, in particular in the field of lung manifestations; pharmaceutical research and development; scientific research and development; medical research laboratory services; medical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services; pharmaceutical drug delivery system development services; pharmaceutical drug development services, namely, preparation and/or formulation of pharmaceuticals; medical product testing services; clinical research and professional expertise relating thereto in the nature of prof...
vicore

General Information


Serial Number79283880
Word MarkVICORE
Filing DateThursday, January 23, 2020
Status700 - REGISTERED
Status DateTuesday, July 6, 2021
Registration Number6405658
Registration DateTuesday, July 6, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 19, 2021

Trademark Statements


Goods and ServicesPharmaceuticals and medical preparations for human use, namely, prescription drugs, namely, pills, tablets, capsules, caplets, and liquid drops sachets for the treatment fibrotic lung disease
Goods and ServicesMedical and pharmacological research services; medical and pharmacological research services within the fields of pulmonary diseases, cardiovascular diseases, autoimmune and inflammatory diseases, fibrotic diseases and kidney diseases; medical and pharmacological research services within the fields of pulmonary fibrosis, namely, ipf, pulmonary sarcoidosis and diffuse systemic sclerosis, in particular in the field of lung manifestations; pharmaceutical research and development; scientific research and development; medical research laboratory services; medical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services; pharmaceutical drug delivery system development services; pharmaceutical drug development services, namely, preparation and/or formulation of pharmaceuticals; medical product testing services; clinical research and professional expertise relating thereto in the nature of professional expertise in the field of clinical research for others; all of the foregoing services for the treatment of fibrotic lung disease

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 24, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 24, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVicore Pharma AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSE

Party NameVicore Pharma AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSE

Party NameVicore Pharma AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSE

Trademark Events


Event DateEvent Description
Sunday, October 22, 2023NEW REPRESENTATIVE AT IB RECEIVED
Friday, January 21, 2022NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, November 23, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, November 1, 2021FINAL DISPOSITION NOTICE SENT TO IB
Monday, November 1, 2021FINAL DISPOSITION PROCESSED
Wednesday, October 6, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 6, 2021REGISTERED-PRINCIPAL REGISTER
Monday, May 31, 2021EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, February 16, 2021EXTENSION OF TIME TO OPPOSE RECEIVED
Sunday, January 24, 2021NOTIFICATION PROCESSED BY IB
Tuesday, January 19, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 19, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 30, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 30, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 30, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 14, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 17, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 16, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 16, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 29, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 29, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 29, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 29, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 29, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 29, 2020REFUSAL PROCESSED BY IB
Thursday, May 14, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, May 14, 2020REFUSAL PROCESSED BY MPU
Friday, May 1, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, April 30, 2020NON-FINAL ACTION WRITTEN
Tuesday, April 28, 2020APPLICATION FILING RECEIPT MAILED
Friday, April 24, 2020ASSIGNED TO EXAMINER
Friday, April 24, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 23, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB